Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works through a subcutaneous injection—meaning the needle penetrates the skin layer to reach the tissue underneath, not the deep fat deposits themselves. Understanding correct injection anatomy and technique improves medication effectiveness and reduces injection-site discomfort.
Subcutaneous Injection Depth and Semaglutide Administration
Semaglutide injections are administered into the hypodermis, the fatty tissue layer directly beneath the outer skin. A standard needle depth of one-quarter to one-half inch allows the medication to reach the subcutaneous space where it disperses evenly into the bloodstream. This shallow penetration is intentional—it prevents the needle from reaching muscle tissue or deeper structures that could cause pain or reduced absorption.
The subcutaneous route creates an optimal depot for medication release. Once injected, semaglutide gradually absorbs into the vascular system over several days, maintaining steady GLP-1 receptor activation throughout the week. Patients often mistake this layer for 'fat injection,' but the hypodermis is a distinct physiological compartment designed for depot medications like GLP-1 agonists and insulin.
Ideal Injection Sites for Semaglutide: Abdomen, Thigh, and Upper Arm
PlexusDx recommends three primary injection sites: the lower abdomen (excluding a 2-inch radius around the navel), the outer thigh, and the back of the upper arm. These areas contain adequate subcutaneous tissue and allow for comfortable, repeatable weekly injections. Rotating between sites reduces local irritation, bruising, and lipodystrophy—abnormal fat changes that can occur with repeated injections in the same location.
The abdomen offers the fastest absorption due to higher blood flow in this region, making it ideal when consistent dosing timing matters most. The thigh and upper arm absorption rates are slightly slower but equally effective. Patients should wait at least one week before returning to a previously injected site, ensuring adequate tissue recovery and maintaining medication bioavailability.
Step-by-Step Semaglutide Injection Technique for Safety and Comfort
Begin by cleaning the injection site with an alcohol swab, allowing the area to air-dry for 30 seconds. Pinch the skin gently between two fingers to create a raised fold—this ensures the needle stays in the subcutaneous layer rather than penetrating deeper. Insert the needle at a 45-degree angle in a quick, confident motion. Hold the position for three seconds before withdrawing to allow the full dose to enter the tissue without backflow.
After injection, release the pinched skin and apply gentle pressure with a cotton ball if bleeding or oozing occurs. Do not rub the injection site, as this can trigger histamine release and increase bruising. Allow the area to settle for 15 minutes before dressing or applying pressure. Most patients report minimal discomfort with proper technique—a slight burning sensation for a few seconds is normal and resolves within minutes.
Personalized Injection Success with PlexusDx Genetic Testing
Individual response to semaglutide varies partly due to genetic factors affecting GLP-1 receptor sensitivity and appetite regulation. PlexusDx Precision Peptide Genetic Test analyzes key variants like GLP1R rs6923761 and MC4R rs17782313, revealing how your genetic profile influences medication response and optimal dosing strategy. This test identifies whether genetic predispositions favor faster or slower semaglutide titration, helping clinicians refine injection protocols for maximum results.
Understanding your genetic pathway allows PlexusDx providers to anticipate side effects, optimize injection timing, and predict likelihood of sustained weight loss response. Patients with certain genetic profiles may absorb semaglutide faster from specific injection sites, or tolerate dose escalation differently. The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment, providing personalized insights that improve injection timing and overall therapy success.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I inject semaglutide directly into body fat?
No. Semaglutide targets the subcutaneous tissue layer just beneath the skin, not deeper fat deposits. This shallow injection depth ensures proper medication absorption and reduces pain. The needle typically penetrates only one-quarter to one-half inch.
What needle size and angle should I use for semaglutide?
Standard semaglutide pens use a 30-gauge needle, one-half inch in length. Insert at a 45-degree angle after pinching the skin fold, hold for three seconds, then withdraw. This angle keeps the medication in the subcutaneous space where it absorbs most effectively.
How often can I inject semaglutide in the same spot?
Wait at least seven days between injections at the same site. Rotating between abdomen, thigh, and upper arm prevents lipodystrophy, tissue damage, and bruising. Consistent site rotation maintains reliable medication absorption week to week.
What side effects can poor injection technique cause?
Incorrect depth or angle may cause bruising, nerve irritation, or muscle injection pain. Repeated injections in the same spot can trigger lipodystrophy or hardened tissue nodules. Proper technique—shallow angle, site rotation, and adequate skin pinching—minimizes these risks significantly.
Does PlexusDx provide guidance on injection administration?
PlexusDx supplies compounded semaglutide from licensed 503A pharmacies with detailed patient instructions included. Your provider also reviews proper technique at setup. The Precision Peptide Genetic Test ($99 add-on) further personalizes your injection protocol based on genetic factors affecting medication response and absorption.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Why GLP-1: Understanding the Role of GLP-1 Agonists in Weight Management and Diabetes
Unlocking Your Potential: When and How to Safely Increase Your Semaglutide Dose